Assessment and management of pregnancy in patients with myeloproliferative neoplasms: insights from a single-institution study of 29 neonates

Int J Hematol. 2024 Dec 6. doi: 10.1007/s12185-024-03893-y. Online ahead of print.

Yoko Edahiro¹, Shuichi Shirane^{2

3}, Jun Takeda⁴, Hajime Yasuda², Tadaaki Inano^{2

3}, Miyuki Tsutsui², Yasuharu Hamano², Makoto Sasaki², Jun Ando^{2

5}, Atsuo Itakura⁴, Miki Ando², Norio Komatsu^{2

3

6}

¹ Department of Hematology, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan. [email protected].
² Department of Hematology, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan.
³ Department of Advanced Hematology, Juntendo University School of Medicine, Tokyo, Japan.
⁴ Department of Obstetrics and Gynecology, Juntendo University School of Medicine, Tokyo, Japan.
⁵ Department of Cell Therapy and Blood Transfusion Medicine, Juntendo University School of Medicine, Tokyo, Japan.
⁶ PharmaEssentia Japan KK, Tokyo, Japan.

No abstract available

Keywords: Essential thrombocythemia; Interferon; Polycythemia vera; Pregnancy.

Publication types